Dr. Jyoti Patel on Delaying Whole Brain Radiation for Brain Metastases

Oncology nurses can ensure patients with non–small cell lung cancer receive the optimal treatment quickly by understanding comprehensive genomic profiling.

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

The investigational BET inhibitor is being investigated combined with abemaciclib or cisplatin/etoposide in NUT carcinoma in 2 clinical trials.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Sunvozertinib has received accelerated approval for use in advanced or metastatic non–small lung cancer harboring EGFR exon 20 insertion mutations.

Oncologic therapies approved in June included indications in genitourinary, lung, hematologic, and head and neck cancers.